Deutsche Bank Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Hold; Like Early Pipeline but Risk/Reward not Favorable
Tweet Send to a Friend
Deutsche Bank downgraded BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from Buy to Hold. PT $27.
Deutsche analyst says, "Top-line results from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Deutsche analyst says, "Top-line results from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
